ARE

Alexandria Real Estate Equities, Inc.

Real EstateREIT - OfficeNASDAQ

$49.68

+$1.90 (3.82%)today

Conviction

6/ 10

Fair Value$58.57

Upside+17.90%

Signal10.74

Market Cap$7.5B

52W Range$41.44–$88.24

Next EarningsApr 27

Conviction History

Conviction Changes

Mar 18, 2026, 7:03 PM5→6conviction-rescore

Premium Content

Upgrade to premium to see the full reasoning behind each conviction change.

Price History

FAIR VALUE ANALYSISMonte Carlo · 5,000 runs · 99% valid

Fair Value$57.43

Current Price$46.04

Upside / Down+24.7%

P(Undervalued)89.2%

P(20%+ Up)58.9%

P(15%+ Down)0.9%

Fair Value Distribution — percentile bands

89.2% of simulations place fair value above current price

WHAT IS PRICED IN

Revenue-Based Reverse DCF

-1.2%/yr

±3.3% · revenue growth to justify current price

FCF-Based Reverse DCF

6.1%/yr

±2.6% · FCF growth to justify current price

THE GAP

Market pricing margin compression or rising capex

Premium Content

Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.

Bull Case

Alexandria Real Estate life science REIT; cluster campus model in Boston/SF; biopharma tenant base.

Bear Case

Biotech funding crunch reducing lab demand; sublease supply in Cambridge/South SF; high capex.

Updated Apr 7

Research Feed

sec_10kMar 4

Conviction: unchanged

ARE 10-K Filing Analysis - FY 2025

ARE 10-K shows headwinds: occupancy 90.9% vs 95% 10yr avg, 45% dividend cut signals confidence loss. Tenant funding constraints post-SVB, construction cost inflation, 3.5M RSF execution risk. Concentr...